02005 石四藥集團
按盘价 
3.920 0.000 (0.000%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 11.500% | 10.361% | 7.870% | 7.209% | 15.558% |
| 股东资金回报率 (%) | 20.061% | 18.063% | 13.235% | 11.505% | 24.631% |
| 资本运用回报率 (%) | 13.961% | 13.547% | 9.448% | 8.576% | 18.481% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 56.005% | 55.449% | 59.182% | 63.563% | 62.059% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 31.633% | 27.889% | 25.704% | 25.258% | 35.982% |
| 税前边际利润率 (%) | 24.502% | 21.746% | 17.705% | 17.020% | 29.362% |
| 纯利率 (%) | 20.403% | 17.452% | 14.664% | 14.362% | 24.508% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 2.032 X | 1.824 X | 2.040 X | 2.011 X | 2.134 X |
| 速动比率 (X) | 1.601 X | 1.521 X | 1.694 X | 1.710 X | 1.812 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 39.257% | 40.311% | 39.370% | 36.077% | 32.847% |
| 总债项 / 总资产比率 (%) | 28.197% | 29.266% | 29.021% | 26.318% | 21.997% |
| 净债项 / 总资产比率 (%) | 14.699% | 14.060% | 13.504% | 10.692% | 11.415% |
| 总债项 / 股东资金比率 (%) | 48.670% | 51.652% | 49.974% | 43.088% | 34.076% |
| 长期债项 / 股东资金比率 (%) | 28.147% | 25.131% | 27.184% | 19.543% | 17.645% |
| 净债项 / 股东资金比率 (%) | 25.371% | 24.815% | 23.253% | 17.506% | 17.683% |
| 净现金 / (债项) ($) | (17.59亿) | (15.42亿) | (14.46亿) | (9.89亿) | (8.82亿) |
| 每股净现金 / (债项) ($) | (0.592) | (0.518) | (0.483) | (0.325) | (0.291) |
| 总债项 / 资本运用比率 (%) | 35.724% | 38.721% | 37.379% | 34.128% | 27.641% |
| 利息盈利率 (X) | 13.627 X | 16.854 X | 16.472 X | 15.090 X | 25.628 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 121.754日 | 104.298日 | 122.345日 | 134.622日 | 96.439日 |
| 应收贸易帐周转率日数 (日) | 121.132日 | 117.335日 | 130.732日 | 154.904日 | 121.047日 |
| 应付贸易帐周转率日数 (日) | 21.715日 | 21.635日 | 21.881日 | 17.662日 | 12.610日 |
| 备注： | 实时报价更新时间为04/09/2024 08:44 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | HKD 685,737 |
| 增长率 | 7.379% |
| 每股盈利/(亏损) | HKD 0.231 |
| 每股账面资产净值 ($) | HKD 2.443 |